What type of study is this?

December 8, 2025Blood

Intravenous iron administration during sepsis: Outcomes, safety, and hemoglobin response

View Full Paper

Ask AI

Bookmark

Authors

Retrospective cohort study shows IV iron reduces 30-day mortality in sepsis patients, suggesting safety in treatment.

IV iron administration significantly reduced mortality at 14, 30, 60, and 90 days in sepsis patients.
The risk difference for 30-day mortality was −3.5%, indicating improved outcomes for IV iron users.
Propensity score matching helped account for confounders like comorbidities and baseline hemoglobin levels.
Findings support the safe use of IV iron in sepsis, challenging prior concerns over its administration during infection.

Omar et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark